Birth weight (g) | 2890 (580) | 2960 (510) |
Gestational age (weeks) | 38.0 (2.7) | 38.2 (2.4) |
Day of onset | 6.9 (5.2) | 6.6 (5.0) |
Clinical type of infection |
Disseminated (%) | 15.4 | 26.3 |
Central nervous system (%) | 46.2 | 36.8 |
Skin, eye, and/or mouth (%) | 38.5 | 36.8 |
Viral load* |
Serum (copies/ml) | 102.3 (3.0) | 102.2 (2.4) |
Cerebrospinal fluid (copies/ml) | 102.2 (1.7) | 101.8 (2.4) |
Viral type |
Type 1 (%) | 38.5 | 78.9 |
Type 2 (%) |
53.8
**
|
21.1
**
|
Unknown (%) | 7.7 | 0.0 |
Initial acyclovir treatment |
Start after onset (days) | 4.3 (3.1) | 3.9 (2.2) |
Dose (mg/kg) | 34.2 (6.7) | 32.4 (7.5) |
Duration (days) | 15.2 (6.1) | 16.9 (6.3) |
Prognosis |
Normal (%) |
61.5
***
|
84.2
***
|
Mildly disabled (%) |
0.0
***
|
15.8
***
|
Severely disabled (%) |
23.1
***
|
0.0
***
|
Unknown (%) | 15.4 | 0.0 |